[Use of patient isolation, nonabsorbable antibiotics and intravenous administration of gentamycin for prevention of infectious complications in hemoblastoses during cytostatic therapy].
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009503:Neutropenia / Q000139:chemically induced; D010356:Patient Isolation
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D005839:Gentamicins; D003630:Daunorubicin
Profilaktika infektsionnykh oslozhneniiĭ pri pomoshchi izoliatsii, neabsorbiruemykh antibiotikov i vnutrivennogo vvedeniia gentamitsina u bol'nykh gemoblastozami vo vremia tsitostaticheskoĭ terapii.